2015-7950R Multiparametric Mri's Detection Of Clinically Significant Prostate Cancer
Posted Date: Jun 10, 2019
- Investigator: Sadhna Verma
- Specialties: Cancer, Oncology, Prostate Cancer
- Type of Study: Observational/Survey
The goal of this study is to determine if Gadoxetate Sodium has the same ability as gadolinium to identify prostate cancer by comparing enhancement ratios and to test if the diagnosis from Gadoxetate Sodium-guided imaging can identify more aggressive prostate cancer that are likely to recur.
Criteria:
To Be Eligible You Must Be At Least 18 Years Of Age, Have Localized Prostate Cancer, Normal Liver Function, No Previous Prostatectomany, No Chronic Kidney Disease Or Pacemakers
Keywords:
Prostate Cancer
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com